DFTX
Definium Therapeutics, Inc.
36.70$
-2.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 63.9% | 67.2% | 44.0% | 5.6% | 100.0% | 100.0% | 83.7% | 85.9% | 83.4% | 93.2% | 95.3% | |
| 1.6% | 5.4% | 0.1% | 4.4% | 0.6% | 98.3% | 81.4% | 83.6% | 80.1% | 90.6% | 58.6% | |
| 63.1% | 63.8% | 42.0% | 4.4% | 0.6% | 98.3% | 81.4% | 83.6% | 80.1% | 90.6% | 93.5% | |
| 0.1% | 2.4% | 0.3% | 0.2% | 0.2% | – | – | – | – | – | – | |
| 0.0% | 0.0% | – | 0.0% | 0.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | 12.1% | 11.7% | 16.0% | 6.6% | 4.5% | |
| – | – | – | – | – | – | 4.2% | 2.2% | 0.4% | – | – | |
| 2.6% | 37.2% | 2.0% | 0.2% | 6.8% | 6.9% | 7.5% | 11.2% | 37.3% | 20.1% | 24.5% | |
| 2.6% | 37.2% | 2.0% | 0.2% | 6.8% | 3.7% | 6.3% | 10.5% | 25.9% | 12.9% | 15.2% | |
| – | – | 0.4% | – | – | – | – | 0.0% | – | – | – | |
| – | – | – | – | – | 2.5% | 2.5% | 1.2% | 3.3% | 0.7% | 1.2% | |
| – | – | – | – | – | – | – | – | 11.3% | 7.2% | 9.2% | |
| 97.4% | 62.8% | 98.0% | 99.8% | 93.2% | 93.1% | 92.5% | 88.8% | 62.7% | 79.9% | 75.5% | |
| -107.5% | -246.5% | -45.1% | -73.2% | -124.3% | -54.8% | -83.9% | -114.4% | -233.0% | -132.0% | -132.4% | |
| 27.1% | 39.7% | 6.3% | 8.8% | 12.9% | 21.8% | 16.7% | 18.2% | 31.4% | 233.2% | 20.3% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.